Latest line: A good week for Gilead, bad one for UC

Gilead Sciences

Foster City biotech company creates stir and sees its stock price jump after a report that one of its drugs, remdesivir, showed promising results in treating COVID-19 patients at a Chicago hospital.

University of California 

UC system is hit with $558 million in unanticipated costs in March from coronavirus, as housing and dining revenue plummets, medical centers lose elective surgeries and online costs rise.

Gavin Newsom

Public gives California’s governor an 83% approval rating in recent poll for his handling of the coronavirus crisis. But the pandemic is blowing a big hole in the state budget that he will have to find ways to fix.